CIK 0001736730 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Camp4 Therapeutics Corp
Sign in to watch- Ticker
- CAMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-651-8867
- Business address
- 100 TALCOTT AVENUE, SUITE 201, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $39,600
- in 1 filing
- Open-market sales, last 90 days
- $2,504,037
- in 4 filings
Net −$2,464,437. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-15 | Polaris Management Co. VII, L.L.C. 10% owner | Conversion · Series B Preferred Stock | −277,536 | 0 | ||
| 2024-10-15 | Northpond Ventures II GP, LLC 10% owner | Conversion | +1,003,193 | 1,003,193 | ||
| 2024-10-15 | Northpond Ventures II GP, LLC 10% owner | Conversion | +471,415 | 471,415 | ||
| 2024-10-15 | Northpond Ventures II GP, LLC 10% owner | Purchase | +763,636 | $11.00 | $8.4M | 763,636 |
| 2024-10-15 | Northpond Ventures II GP, LLC 10% owner | Conversion · Series A Prime Preferred Stock | −11,251,624 | 0 | ||
| 2024-10-15 | Northpond Ventures II GP, LLC 10% owner | Conversion · Series B Preferred Stock | −5,287,303 | 0 | ||
| 2024-10-15 | AH Equity Partners Bio I, L.L.C. 10% owner | Conversion | +1,398,067 | 1,398,067 | ||
| 2024-10-15 | AH Equity Partners Bio I, L.L.C. 10% owner | Purchase | +181,818 | $11.00 | $2.0M | 1,579,885 |
| 2024-10-15 | AH Equity Partners Bio I, L.L.C. 10% owner | Purchase | +545,454 | $11.00 | $6.0M | 545,454 |
| 2024-10-15 | AH Equity Partners Bio I, L.L.C. 10% owner | Conversion · Series A Prime Preferred Stock | −15,001,312 | 0 | ||
| 2024-10-15 | AH Equity Partners Bio I, L.L.C. 10% owner | Conversion · Series B Preferred Stock | −679,163 | 0 | ||
| 2024-10-15 | Enavate Sciences GP, LLC 10% owner | Conversion | +2,422,166 | 2,422,166 | ||
| 2024-10-15 | Enavate Sciences GP, LLC 10% owner | Purchase | +1,363,636 | $11.00 | $15.0M | 3,785,802 |
| 2024-10-15 | Enavate Sciences GP, LLC 10% owner | Conversion · Series B Preferred Stock | −27,166,530 | 0 | ||
| 2024-10-15 | 5AM Partners VI, LLC 10% owner | Conversion | +1,716,055 | 1,716,055 | ||
| 2024-10-15 | 5AM Partners VI, LLC 10% owner | Conversion | +302,770 | 302,770 | ||
| 2024-10-15 | 5AM Partners VI, LLC 10% owner | Purchase | +909,090 | $11.00 | $10.0M | 2,625,145 |
| 2024-10-15 | 5AM Partners VI, LLC 10% owner | Conversion · Series A Prime Preferred Stock | −15,002,166 | 0 | ||
| 2024-10-15 | 5AM Partners VI, LLC 10% owner | Conversion · Series B Preferred Stock | −4,244,770 | 0 | ||
| 2024-10-15 | 5AM Partners VI, LLC 10% owner | Conversion · Series B Preferred Stock | −3,395,816 | 0 |
Page 4 of 6 · 111 trades